300529 健帆生物
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额255,891721,2161,050,988916,744883,800
投资活动产生之现金流量净额(2,196,573)643,153(1,127,472)(249,649)(305,901)
筹资活动产生之现金流量净额(83,578)(563,332)(989,821)(451,911)(365,934)
汇率变动对现金及现金等价物的影响(1,821)(1,723)42811(36)
现金及现金等价物净增加/(减少)(2,026,081)799,315(1,065,877)215,195211,929
期初现金及现金等价物余额2,474,9821,675,6662,741,5432,526,3492,314,420
期末现金及现金等价物余额448,9012,474,9821,675,6662,741,5432,526,349